These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2693543

  • 1. [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T, Matsubara Y, Sagara H, Shimizu N, Tomizawa I, Takizawa Y, Nitia Y, Seo T, Kamimura M, Kanehisa N.
    Kansenshogaku Zasshi; 1989 Jul; 63(7):659-75. PubMed ID: 2693543
    [Abstract] [Full Text] [Related]

  • 2. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T, Matsubara Y, Sagara H, Tomizawa I, Takizawa Y, Nitta Y, Seo T, Kamimura M, Masuda G, Negishi M.
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I, Takizawa Y, Nitta Y, Tsunoda T, Fukuda H, Yamaguchi T, Masuda G, Negishi M, Ajisawa A, Murata M, Ohnishi K, Irimajiri S, Obana M, Sajima Y, Sagara H, Kato H, Hosoda S, Banba T, Sasaki M, Yoshikawa K, Nakagawa M, Ohkubo H, Kim Y, Akao M, Fukuyama M.
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [Abstract] [Full Text] [Related]

  • 4. [Basic and clinical studies of pazufloxacin on infectious enteritis research group of T-3761 on infectious enteritis].
    Sagara H, Yoshikawa K, Tomizawa I, Takizawa Y, Nitta Y, Tsunoda T, Fukuda H, Yamaguchi T, Masuda G, Negishi M, Ajisawa A, Murata M, Ohnishi K, Irimajiri S, Obana M, Matsumoto F, Imai T, Sakurai I, Takahashi T, Mori M, Mizuno Y, Katoh K, Hosoda S, Bamba T, Saito M.
    Kansenshogaku Zasshi; 1996 Jan; 70(1):60-72. PubMed ID: 8822054
    [Abstract] [Full Text] [Related]

  • 5. [clinical study of balofloxacin on infectious enteritis and assessment of the fecal drug concentration and intestinal microbial flora in patients with inpatients with infectious enteritis. Research group of balofloxacin on infectious enteritis].
    Obana M, Irimajiri S, Tomizawa I, Takizawa Y, Sakamoto Y, Nitta Y, Tsunoda T, Fukuda H, Yamaguchi T, Masuda G.
    Kansenshogaku Zasshi; 1995 Sep; 69(9):991-1006. PubMed ID: 7594801
    [Abstract] [Full Text] [Related]

  • 6. [Basic and clinical studies of fleroxacin on infectious enteritis. Research Group of AM-833 on infectious enteritis].
    Sagara H, Tomizawa I, Takizawa Y, Nitta Y, Tsunoda T, Yamaguchi T, Masuda G, Negishi M, Ajisawa A, Murata M.
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1390-408. PubMed ID: 7829908
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of clinical efficacy of lomefloxacin (LFLX, NY-198) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Lomefloxacin Research Group Enteritis].
    Aoki T, Shimizu N, Tomizawa I, Takizawa Y, Matsubara Y, Nitta Y, Sagara H, Seo T, Kanehisa N, Murata M.
    Kansenshogaku Zasshi; 1989 Jun; 63(6):606-22. PubMed ID: 2693542
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antibacterial activity of pazufloxacin (PZFX) against clinical isolates from infectious enteritis].
    Fukuyama M, Oonaka K, Hara M, Imagawa Y.
    Kansenshogaku Zasshi; 1996 Jan; 70(1):51-9. PubMed ID: 8822053
    [Abstract] [Full Text] [Related]

  • 9. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Jan; 11(4):253-7. PubMed ID: 2941257
    [Abstract] [Full Text] [Related]

  • 10. [In vitro antibacterial activity of balofloxacin (BLFX) against isolates from patients with bacterial enteritis].
    Fukuyama M, Kawakami K, Suda O, Imagawa Y.
    Kansenshogaku Zasshi; 1995 Sep; 69(9):987-90. PubMed ID: 7594800
    [Abstract] [Full Text] [Related]

  • 11. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
    Obana M, Matsuoka Y, Irimajiri S, Tonooka H.
    Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
    [Abstract] [Full Text] [Related]

  • 12. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Jul; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 13. [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis].
    Sugata F, Ohguri S, Takamura Y, Tominaga S, Iwamura K, Yamada T, Shibata H, Yamada N, Okabe K, Kato Y.
    Jpn J Antibiot; 1989 Sep; 42(9):1873-81. PubMed ID: 2810750
    [Abstract] [Full Text] [Related]

  • 14. Salmonella excretion after cessation of tosufloxacin therapy in acute nontyphoid salmonella enterocolitis.
    Ohnishi K, Kimura K.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1892-3. PubMed ID: 11353646
    [Abstract] [Full Text] [Related]

  • 15. [Rational therapy of salmonella enteritis].
    Hof H, Kretschmar M.
    Leber Magen Darm; 1994 Mar; 24(2):57-8, 61-4. PubMed ID: 8196466
    [Abstract] [Full Text] [Related]

  • 16. Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days.
    Voltersvik P, Halstensen A, Langeland N, Digranes A, Peterson LE, Rolstad T, Solberg CO.
    J Antimicrob Chemother; 2000 Sep; 46(3):457-9. PubMed ID: 10980174
    [Abstract] [Full Text] [Related]

  • 17. [A clinical experience of rokitamycin on Campylobacter enteritis. Research Group of Rokitamycin on Infectious Enteritis].
    Irimajiri S, Sagara H, Tomizawa I, Takizawa Y, Nitta Y, Seo T, Sato J, Tsunoda T, Ota S, Nakamura Y.
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1153-64. PubMed ID: 1761895
    [Abstract] [Full Text] [Related]

  • 18. [In vitro antibacterial activity of fleroxacin (FLRX) against clinical isolates from bacterial enteritis].
    Imagawa Y, Fukuyama M, Kawakami K, Suda O.
    Kansenshogaku Zasshi; 1994 Nov; 68(11):1409-16. PubMed ID: 7829909
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
    Fujii R, Meguro H, Arimasu O, Ushijima K, Abe T, Nakazawa S, Sato H, Narita A, Niino K, Ichihashi H.
    Jpn J Antibiot; 1990 Jan; 43(1):181-215. PubMed ID: 2190014
    [Abstract] [Full Text] [Related]

  • 20. Fluoroquinolones and bacterial enteritis, when and for whom?
    Wiström J, Norrby SR.
    J Antimicrob Chemother; 1995 Jul; 36(1):23-39. PubMed ID: 8537271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.